New Mexico med spa & injectable regulations
What’s changing for med spas and injectors in New Mexico — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in New Mexico. MedSpaRadar monitors it all and tells you, in plain language, what changed and what to do.
Opening a med spa in New Mexico? Start with who may own one, the medical director rules, and who may inject in New Mexico →
Latest New Mexico changes
No New Mexico-specific changes have crossed our radar yet — we’re monitoring the New Mexico legislature daily. The New Mexico legislature has adjourned sine die (2026 Regular Session). No further session is listed yet. The federal changes below apply to every New Mexico practice today.
Federal changes that apply in New Mexico
FDA and Federal Register actions are nationwide — they govern New Mexico practices too.
- MONITORFEDERALPrimary Source MonitoringSep 21, 2026
Primary Source Monitoring: Former Connecticut Resident Guilty of Operating Websites to Illegally Sell Misbranded and Unapproved Drugs
Caution urged due to recent conviction for selling misbranded drugs.
- MONITORFEDERALPrimary Source MonitoringSep 17, 2026
Primary Source Monitoring: Korea Filler Experts - 718706 - 11/03/2025
FDA warns koreafillerexperts.com over unapproved, misbranded injectable botulinum toxin.
- CRITICALFEDERALFDA Device RecallSep 16, 2026
FDA device recall (Class II): Product Name: DermaV Laser System Model/Catalog Number: DermaV Medical laser device that delivers pulsed laser energy a…
FDA recalls DermaV Laser System; check for safety compliance.
- MONITORFEDERALPrimary Source MonitoringSep 16, 2026
Primary Source Monitoring: FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize
FDA updates compounding guidelines as GLP-1 supplies stabilize.
- MONITORFEDERALPrimary Source MonitoringSep 15, 2026
Primary Source Monitoring: Hefner v. Rock Valley Compounding Pharmacy, LLC (3:26-cv-01298) — District Court, S.D. Illinois
Legal case filed affecting compounding pharmacy standards.
- MONITORFEDERALPrimary Source MonitoringSep 9, 2026
Primary Source Monitoring: Human Drug Compounding Policies and Rules
FDA's compounding policy index adds a September 2026 neonatal nutrition guidance.
What we monitor in New Mexico
- New Mexico legislature — bills on injectables, GLP-1s & scope of practice
- New Mexico Medical Board — Board notices for the body that writes New Mexico’s delegation and supervision rules.
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
New Mexico med spa questions, answered from statute
The same verified record, asked the way operators actually ask it — who may own one, who may inject, what the supervising physician has to do. 23 questions have a cited New Mexico answer today.
Browse the 23 New Mexico questions →New Mexico med-spa compliance rules
41 rules across 7 topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.
Physician supervision & delegation7 cited rules
New Mexico wrote a rule for this exact business, and it is recent. 16.12.14 NMAC — "Nursing Practice in Aesthetic Healthcare Facilities", effective 2024-05-21 — defines an aesthetic healthcare facility and requires it to employ a clinical supervisor who is an APRN or other licensed independent practitioner with…
- All 7 cited rules: New Mexico medical director requirements →
- Does a med spa in New Mexico need a medical director? →
- What must the supervising physician actually do in New Mexico? →
- Who may operate a cosmetic laser in New Mexico? →
- Can a medical assistant give injections in New Mexico? →
- Must someone be on site while a patient is treated in New Mexico? →
- May an esthetician or laser technician perform microneedling in New Mexico? →
Good-faith examination8 cited rules
Before any aesthetic healthcare procedure, an APRN or other licensed independent practitioner must conduct a FACE-TO-FACE assessment, determine a diagnosis and prescribe a treatment plan — and "may never delegate the examination, diagnosis, or treatment plan".
Ownership & corporate practice of medicine3 cited rules
Sections 61-6-1 through 61-6-35 contain no professional-corporation requirement and no restriction on who may hold an ownership interest in a medical practice — the words "corporation", "shareholder", "partnership" and "limited liability" do not appear in the Act at all.
RN / NP scope for injectables8 cited rules
An APRN with the appropriate population foci, licensure, national certification and education may perform aesthetic healthcare procedures and is the only nursing license that may serve as a clinical supervisor.
Disciplinary landscape6 cited rules
New Mexico puts practice without a license at the top of its unprofessional-conduct rule and gives the state a civil route as well as a disciplinary one. The medical board’s ethics rule lists practicing medicine without an active license, deceptive or anonymous advertising, improper use of a fictitious name, dishonesty and making or signing false documents among the acts that constitute unprofessional or dishonorable conduct. The Act adds conduct likely to deceive, defraud or harm the public, makes practicing without a license a fourth degree felony, and by § 61-6-22 lets the attorney general, the prosecuting attorney, the board or any citizen of the county maintain an action to ENJOIN an unlicensed practitioner until a license is secured.
As defined in the Medical Practice Act, Section 61-6-15,D,(29), “unprofessional or dishonorable conduct” includes, but is not limited to, the following: A. practicing medicine without an active license;
G. making or signing false documents; H. dishonesty; I. deceptive or anonymous advertising; J. improper use of a fictitious name; K. violation of a term of a stipulation;
16.10.8.8(G)-(K) NMAC (Unprofessional or dishonorable conduct)
(18) conduct likely to deceive, defraud or harm the public;
N.M. Stat. Ann. § 61-6-15(D)(18) (Unprofessional or dishonorable conduct)
The attorney general, the prosecuting attorney, the board or any citizen of any county where any person engages in the practice of medicine as defined by the laws of New Mexico without possessing a valid license to do so may, in accordance with the laws of the state governing injunctions, maintain an action in the name of the state to enjoin such person from engaging in the practice of medicine until a valid license to practice medicine is secured from the board.
N.M. Stat. Ann. § 61-6-22 (Injunction to prevent practice without a license)
Any person who practices medicine or who attempts to practice medicine without first complying with the provisions of the Medical Practice Act and without being the holder of a license entitling him to practice medicine in New Mexico is guilty of a fourth degree felony.
A complaint committee shall review each complaint charging a physician, physician assistant, anesthesiologist assistant, genetic counselor, or polysomnographic technologist with unprofessional conduct or other violations under the Medical Practice Act.
16.10.6 NMAC (Complaint procedure and institution of disciplinary action)
Med-spa registration & licensing6 cited rules
⚠️ New Mexico reaches the facility through the licensees inside it. 16.12.14 NMAC, effective 2024-05-21, defines an aesthetic healthcare facility as a business or other practice that provides aesthetic healthcare procedures to the general public, — the definition that brings a med spa inside the nursing board’s reach at all. Every patient encounter must generate a healthcare record, and the medical board separately requires licensees and health care entities to report malpractice payments and professional review actions. Whether New Mexico also registers such a facility as premises was not surveyed here. On compounded drugs the Board of Pharmacy’s non-sterile compounding part is direct: a non-sterile drug product may be compounded in a licensed pharmacy as a result of a practitioner’s prescription order based on the practitioner-patient-pharmacist relationship, or in limited anticipatory quantities on a history of valid prescriptions within that relationship, and a commercially available product may be compounded for dispensing to individual patients only where it is not reasonably available through normal channels in time to meet the patient’s needs and the prescriber has requested compounding, or where the compounded product is changed to produce a significant difference for that patient as the prescriber authorizes or is in the patient’s best interest — with the prescriber and patient informed that the product will be compounded. Sterile compounding is governed separately and is not surveyed by these claims.
“Aesthetic healthcare facility” means a business or other practice that provides aesthetic healthcare procedures to the general public .
Every patient encounter in an aesthetic healthcare facility must generate a healthcare record.
16.12.14.11(A) NMAC (Patient records, confidentiality, and advertising)
this part defines the requirements for affected entities to report to the board: (1) payments relating to malpractice actions or claims arising in New Mexico involving licensees and applicants; (2) professional review actions;
16.10.10 NMAC (Reporting requirements for licensees, applicants and other persons and entities)
New Mexico publishes the cost of entry as a fee rule, so this is the price rather than an estimate. 16.34.14.8 FEES: The board or department, where applicable, may charge the following fees: A. Enterprise or establishment license (original): $200.00 B. Enterprise or establishment license (renewal): $50.00. A School license (original and renewal) is $500.00. Part 14 exists to set fees; the civil penalties in Part 15 are a different instrument and are not what it costs to open.
16.34.14.8 NMAC (the establishment fee a new studio actually pays)
New Mexico lets a pharmacy compound a commercially available product for dispensing only on stated conditions, which is the compounded-semaglutide question in one paragraph. Commercially available product may be compounded for dispensing to individual patients provided the following conditions are met: (a) the commercial product is not reasonably available from normal distribution channels in a timely manner to meet patient’s needs; and (b) the prescribing practitioner has requested that the drug be compounded; or (c) if the compounded product is changed to produce for that patient a significant difference, as authorized by the prescriber, between the compounded drug and the comparable commercially available drug product, or if use of the compounded product is in the best interest of the patient; when a compounded product is to be dispensed in place of a commercially available product, the prescriber and patient shall be informed that the product will be compounded.
16.19.30.9(A)(3) NMAC (Compounding of Non-Sterile Pharmaceuticals — commercially available products)
Non-sterile drug products may be compounded in licensed pharmacies as a result of a practitioner’s prescription order based on the practitioner-patient-pharmacist relationship in the course of professional practice. (2) Preparing limited quantities of prescription drug orders in anticipation based upon a history of receiving valid prescriptions issued within an established practitioner-patient-pharmacist relationship in the course of professional practice.
16.19.30.9(A)(1)-(2) NMAC (Compounding of Non-Sterile Pharmaceuticals — general requirements)
Advertising rules3 cited rules
The nursing rule states that advertising and marketing of aesthetic healthcare procedures is regulated and may not be deceptive, false or misleading, and requires a licensee to reference only their ACTIVE license and never to hold out services they are not licensed to provide.
Current as of Sep 8, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.
Who may perform it in New Mexico?
We hold New Mexico’s own written limits for chemical peel, injectable (neuromodulator, dermal filler), microneedling / collagen induction, body contouring (cryolipolysis, RF, ultrasound), mechanical exfoliation (dermaplaning, microdermabrasion), energy device (laser, IPL, RF, plasma, ultrasound), hair removal (laser / IPL) — read at source and cited. Check a licence against a procedure and see the rule it rests on.
Check scope in New Mexico →New Mexico med spa compliance — FAQ
- Where do New Mexico med spa and injectable regulations come from?
- New Mexico med spas and injectors are governed by a mix of state and federal authorities — the New Mexico legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. MedSpaRadar monitors all of them for New Mexico and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in New Mexico?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in New Mexico. We track those federal changes alongside any New Mexico-specific rules so you see the full picture for your practice.
- How do I keep up with New Mexico regulatory changes?
- MedSpaRadar sends a free weekly Brief on what changed across New Mexico, the FDA, and the Federal Register. Members get the exact "what to do" for their states in one daily email. It's regulatory monitoring, not legal advice.
Get New Mexico changes as they publish
We scan the New Mexico legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
Related
- The Practice Perimeter — the decisions every state makes about a practice, and where each answer lives
- MedSpaRadar vs an AmSpa membership — published prices, what each includes, and when a membership is the better buy
- “Med spa compliance software” means two different things — which half of compliance you are actually shopping for
← All states · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director.